NOT KNOWN DETAILS ABOUT LINK ALTERNATIF MBL77

Not all people with CLL need therapy. Even with all recent advances, the iwCLL still endorses watchful observation for people with asymptomatic illness.86 This suggestion relies on at least two randomized trials comparing observation to either chlorambucil monotherapy or fludarabine, cyclophosphamide and rituximab (FCR).Klik tombol daftar di situs